These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6723675)

  • 1. The immediate effects of retrograde pancreatography on the pancreas.
    Kivisaari L; Alitalo I
    Eur J Radiol; 1984 Feb; 4(1):58-60. PubMed ID: 6723675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model.
    Pfau PR; Mosley RG; Said A; Gopal DV; Fischer MC; Oberley T; Weiss J; Lee FT; Eckoff D; Reichelderfer M
    JOP; 2006 Jan; 7(1):27-33. PubMed ID: 16407615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Banerjee A
    Am J Gastroenterol; 1992 May; 87(5):683-4; author reply 684-5. PubMed ID: 1595671
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of contrast agents for endoscopic retrograde pancreatography.
    Barkin JS; Casal GL; Reiner DK; Goldberg RI; Phillips RS; Kaplan S
    Am J Gastroenterol; 1991 Oct; 86(10):1437-41. PubMed ID: 1928034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental pancreatography: a comparison of three contrast media.
    Saari A; Kivisaari L; Standertskjöld-Nordenstam CG; Brackett K; Schröder T
    Scand J Gastroenterol; 1988 Jan; 23(1):53-8. PubMed ID: 3344398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Cotton PB; Brazer SR
    Am J Gastroenterol; 1992 May; 87(5):683; author reply 684-5. PubMed ID: 1595670
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute pancreatitis following endoscopic retrograde cholangiopancreatography.
    Hamilton I; Lintott DJ; Rothwell J; Axon AT
    Clin Radiol; 1983 Sep; 34(5):543-6. PubMed ID: 6617085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Short TP; Thomas E
    Am J Gastroenterol; 1992 May; 87(5):682-3; author reply 684-5. PubMed ID: 1595669
    [No Abstract]   [Full Text] [Related]  

  • 9. Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate.
    O'Connor HJ; Ellis WR; Manning AP; Lintott DJ; McMahon MJ; Axon AT
    Endoscopy; 1988 Sep; 20(5):244-7. PubMed ID: 3168937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP.
    Ogawa M; Kawaguchi Y; Kawashima Y; Mizukami H; Maruno A; Ito H; Mine T
    Tokai J Exp Clin Med; 2013 Sep; 38(3):109-13. PubMed ID: 24030487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
    Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
    JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERCP and endoscopic sphincterotomy-induced pancreatitis.
    Sherman S
    Am J Gastroenterol; 1994 Mar; 89(3):303-5. PubMed ID: 8122635
    [No Abstract]   [Full Text] [Related]  

  • 13. Metrizamide as contrast medium in endoscopic retrograde cholangio-pancreatography.
    Hamilton I; Lintott DJ; Rothwell J; Axon AT
    Clin Radiol; 1982 May; 33(3):293-5. PubMed ID: 7042178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation.
    Tsujino T; Isayama H; Komatsu Y; Ito Y; Tada M; Minagawa N; Nakata R; Kawabe T; Omata M
    Am J Gastroenterol; 2005 Jan; 100(1):38-42. PubMed ID: 15654778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In-vitro experiments to study the role of contrast medium in pancreatitis due to ERCP (author's transl)].
    Stock KP; Riemann JF
    Z Gastroenterol; 1981 Mar; 19(3):128-34. PubMed ID: 6165148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pancreatitis on the absorption of contrast medium from the pancreatic duct.
    Saari A; Kivisaari L; Pitkäranta P; Nuutinen P; Schröder T
    Ann Chir Gynaecol; 1988; 77(4):146-50. PubMed ID: 3254095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thalidomide in experimental models of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Xiong GS; Wu SM; Wang ZH; Mo JZ; Xiao SD
    J Gastroenterol Hepatol; 2007 Mar; 22(3):371-6. PubMed ID: 17295769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, prospective study comparing two contrast media in ERCP.
    Cunliffe WJ; Cobden I; Lavelle MI; Lendrum R; Tait NP; Venables CW
    Endoscopy; 1987 Sep; 19(5):201-2. PubMed ID: 3678161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of hyperamylasemia after ERCP with diatrizoate and iohexol.
    Mäkelä P; Dean PB
    Eur J Radiol; 1986 Nov; 6(4):303-4. PubMed ID: 2431908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.